Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Teva Pharmaceutical Industries Ltd. (TEVA) had Income from Continuous Operations of $434.00M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$4.48B |
|
$433.00M |
|
$2.18B |
|
$2.30B |
|
$3.60B |
|
$882.00M |
|
$-237.00M |
|
$646.00M |
|
$646.00M |
|
$432.00M |
|
|
Income from Continuous Operations |
$434.00M |
$434.00M |
|
$432.00M |
|
$882.00M |
|
$1.13B |
|
1.15B |
|
1.16B |
|
$0.38 |
|
$0.37 |
|
| Balance Sheet Financials | |
$12.74B |
|
$4.82B |
|
$27.12B |
|
$39.86B |
|
$11.49B |
|
$16.77B |
|
$21.11B |
|
$32.60B |
|
$7.25B |
|
$-12.63B |
|
$7.25B |
|
1.15B |
|
| Cash Flow Statement Financials | |
$491.00M |
|
$572.00M |
|
$-2.19B |
|
$3.30B |
|
$2.20B |
|
$-1.10B |
|
$106.00M |
|
$-340.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.11 |
|
-- |
|
-- |
|
0.70 |
|
2.31 |
|
51.43% |
|
19.69% |
|
19.69% |
|
-- |
|
14.42% |
|
9.67% |
|
$166.00M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.65 |
|
1.18 |
|
76.54 |
|
5.98% |
|
-3.44% |
|
1.09% |
|
1.81% |
|
$6.32 |
|
$0.14 |
|
$0.42 |
|